ADIPOQ and metabolic dysfunction-associated steatohepatitis: Reduced adiponectin levels could create a proinflammatory environment, making people more susceptible to lipotoxicity, which encourages the development of non-alcoholic steatohepatitis (NASH) and even advanced hepatic fibrosis from simple steatosis [4].